All lobbying filings

Thegroup DC, LLC

Thegroup DC, LLC filed a Q4 termination report for Orchard Therapeutics North America on January 20, 2026, reporting $50,000 in lobbying income.

Lobbying for Orchard Therapeutics North America · Biotechnology company.

As filed: THEGROUP DC, LLC for ORCHARD THERAPEUTICS NORTH AMERICA.

All filings by Thegroup DC, LLC · Everything Orchard Therapeutics North America has reported

Filing · LD-2 quarterly report Q4 termination

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 20, 2026

Income

$50,000

What the client paid this registrant for the period.

Client based in

Massachusetts

Representation ended

Dec 31, 2025

The registrant reported terminating its work for this client.

Official filing document

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Newborn screening for Metachromatic Leukodystrophy

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.